ABCG2 Antibodies

Santa Cruz Biotechnology features a diverse variety of ABCG2 monoclonal antibodies for research focused on understanding ABCG2 protein function. ABCG2 monoclonal antibodies are compatible with multiple experimental applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ABCG2, also known as the breast cancer resistance protein, is a member of the ATP-binding cassette (ABC) transporter family and plays a crucial role in the efflux of drugs and xenobiotics across cellular membranes. ABCG2 function is particularly important in pharmacology and cancer research, as it contributes to multidrug resistance in cancer cells and affects the bioavailability of therapeutic agents. Understanding the expression and regulation of ABCG2 is vital for developing strategies to overcome drug resistance and improve treatment outcomes. ABCG2 monoclonal antibodies enable researchers to explore drug transport mechanisms and resistance patterns in cancer cells. ABCG2 monoclonal antibodies support investigations into cellular drug resistance mechanisms and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for ABCG2 research contribute to advancing our understanding of drug resistance in cancer treatment and therapeutic development.